Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR)
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the efficacy and safety of an investigational nasal
aerosol compared with placebo nasal aerosol in the treatment of seasonal allergic rhinitis.
Phase:
Phase 3
Details
Lead Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc. Teva Branded Pharmaceutical Products, R&D Inc.